Key result
Metformin cuts aortic valve leaflet opacification ~63% and decreases calcium deposition ex vivo.
Why the study?
Calcific aortic valve disease lacks effective pharmacological treatments, and metformin's role in preventing organic phosphate-induced degeneration in valvular interstitial cells and aortic valve leaflets remains unclear.
p-value: p=0.0052
Should not yet change aortic stenosis management; hypothesis-generating for metformin repurposing in calcific valve disease.
Calcific aortic valve disease (CAVD) is a prevalent valvular disorder that lacks effective pharmacological treatments. Metformin, an oral anti-diabetic drug, has been suggested to protect valvular interstitial cells (VICs) from calcification, but its role in preventing organic phosphate-induced degeneration in VICs and aortic valve (AV) leaflets remains unclear. Using an ex vivo three-dimensional tissue model, we induced degeneration with organic phosphate-rich conditions in ovine VICs and AV leaflets. Metformin treatment reduced calcium deposition, as assessed by alizarin red staining (VICs: p < 0.0001; AV leaflets: p < 0.05), and preserved reduced opacity of AV leaflet (p < 0.01). It inhibited early osteogenic differentiation, evidenced by reduced alkaline phosphatase activity (VICs: p < 0.0001; AV leaflets: p < 0.05), and mitigated gene expression of myofibroblastic markers. Furthermore, metformin improved proliferation (VICs: p < 0.0001; AV leaflets: p < 0.05), lowered lactate dehydrogenase levels (VICs: p < 0.01; AV leaflets: p < 0.001), preserved extracellular matrix architecture, and ameliorated extracellular matrix remodeling at gene expression level. AMPK phosphorylation was increased in both VICs (28%, p < 0.001) and AV leaflets (21%, p < 0.05) under pro-degenerative conditions and metformin treatment. In conclusion, metformin protects against organic phosphate-induced degeneration in both VICs and AV leaflets, highlighting its therapeutic potential in CAVD.
No takes yet. Share an insight, caveat, or question.
Schoettler et al. (2025) studied Calcific aortic valve disease. Metformin vs. Pro-degenerative conditions (organic phosphate-rich) without metformin was evaluated on Opaque areas in aortic valve leaflets (indicative of thickening and calcification) (p=0.0052). Metformin treatment significantly reduced opaque areas in aortic valve leaflets by 63% and decreased calcium deposition in an ex vivo model of calcific aortic valve disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: